New Delhi, Oct 8 (PTI) US-based Amneal Pharmaceuticals on Tuesday said it will invest up to USD 200 million (nearly Rs 1,680 crore) in India over the next four to five years to build two new manufacturing facilities in Ahmedabad.

Of two greenfield facilities planned, one will be for peptide synthesis and one for advanced sterile fill-finish manufacturing, the company said in a statement.

Also Read | Shillong Teer Results Today, October 8 2024: Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

"In this latest expansion in India, Amneal will make a total net investment of between USD 150 million and USD 200 million over the next four to five years to build two new greenfield facilities...," it said.

Commenting on the development, Amneal Pharmaceuticals Co-Founders and Co-Chief Executive Officers Chirag Patel and Chintu Patel said, "With these new facilities, we are proud to be at the forefront of developing and manufacturing innovative, branded medicines at scale in India, which will supply the local market and the rest of the world."

Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for October 8 2024 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game.

The company which started operations in India in 2008, currently has eight manufacturing sites, including five in Ahmedabad with additional sites in Dahej, Hyderabad and Vizag, and commercial offices in Mumbai. It has invested approximately USD 600 million in India over the past 10 years.

These facilities have a collective capacity of producing up to approximately 60 million units of injectables and 8.5 billion tablets annually, the company said.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)